Fresenius SE & Co. KGaA (FRE.DE)
EUR 34.19
(0.41%)
EUR 34.19
(0.41%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.14 Billion EUR | -67.42% |
| 2022 | 3.5 Billion EUR | -15.63% |
| 2021 | 4.15 Billion EUR | -5.18% |
| 2020 | 4.38 Billion EUR | -5.31% |
| 2019 | 4.63 Billion EUR | 4.25% |
| 2018 | 4.44 Billion EUR | -3.2% |
| 2017 | 4.58 Billion EUR | 6.06% |
| 2016 | 4.32 Billion EUR | 11.66% |
| 2015 | 3.87 Billion EUR | 24.44% |
| 2014 | 3.11 Billion EUR | 4.11% |
| 2013 | 2.99 Billion EUR | 0.27% |
| 2012 | 2.98 Billion EUR | 16.39% |
| 2011 | 2.56 Billion EUR | 6.0% |
| 2010 | 2.41 Billion EUR | 17.61% |
| 2009 | 2.05 Billion EUR | 39.2% |
| 2008 | 1.47 Billion EUR | -65.88% |
| 2007 | 4.32 Billion EUR | 7.53% |
| 2006 | 4.02 Billion EUR | 28.22% |
| 2005 | 3.14 Billion EUR | 15.06% |
| 2004 | 2.72 Billion EUR | 260.5% |
| 2003 | 757 Million EUR | -6.54% |
| 2002 | 810 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 265 Million EUR | -52.59% |
| 2024 Q1 | 559 Million EUR | 557.65% |
| 2023 Q4 | 85 Million EUR | -75.43% |
| 2023 FY | 1.14 Billion EUR | -67.42% |
| 2023 Q1 | 787 Million EUR | -9.95% |
| 2023 Q2 | 543 Million EUR | -31.0% |
| 2023 Q3 | 346 Million EUR | -36.28% |
| 2022 Q3 | 887 Million EUR | 4.97% |
| 2022 Q4 | 874 Million EUR | -1.47% |
| 2022 FY | 3.5 Billion EUR | -15.63% |
| 2022 Q1 | 902 Million EUR | -19.68% |
| 2022 Q2 | 845 Million EUR | -6.32% |
| 2021 Q4 | 1.12 Billion EUR | 11.41% |
| 2021 Q2 | 1.02 Billion EUR | 1.49% |
| 2021 Q1 | 1 Billion EUR | -1.85% |
| 2021 Q3 | 1 Billion EUR | -1.27% |
| 2021 FY | 4.15 Billion EUR | -5.18% |
| 2020 Q4 | 1.02 Billion EUR | -7.66% |
| 2020 Q1 | 1.1 Billion EUR | -12.2% |
| 2020 Q2 | 1.11 Billion EUR | 1.54% |
| 2020 Q3 | 1.11 Billion EUR | -0.72% |
| 2020 FY | 4.38 Billion EUR | -5.31% |
| 2019 FY | 4.63 Billion EUR | 4.25% |
| 2019 Q1 | 1.11 Billion EUR | -10.94% |
| 2019 Q4 | 1.25 Billion EUR | 11.37% |
| 2019 Q3 | 1.12 Billion EUR | 1.72% |
| 2019 Q2 | 1.1 Billion EUR | -0.72% |
| 2018 Q3 | 1.03 Billion EUR | -7.12% |
| 2018 Q4 | 1.25 Billion EUR | 21.44% |
| 2018 FY | 4.44 Billion EUR | -3.2% |
| 2018 Q1 | 1.03 Billion EUR | -5.13% |
| 2018 Q2 | 1.11 Billion EUR | 7.14% |
| 2017 Q1 | 1.21 Billion EUR | -1.54% |
| 2017 Q4 | 1.09 Billion EUR | -1.97% |
| 2017 Q3 | 1.11 Billion EUR | -4.54% |
| 2017 FY | 4.58 Billion EUR | 6.06% |
| 2017 Q2 | 1.16 Billion EUR | -4.03% |
| 2016 Q4 | 1.23 Billion EUR | 14.14% |
| 2016 Q2 | 1.05 Billion EUR | 9.59% |
| 2016 Q1 | 959 Million EUR | -9.01% |
| 2016 FY | 4.32 Billion EUR | 11.66% |
| 2016 Q3 | 1.08 Billion EUR | 2.95% |
| 2015 Q1 | 873 Million EUR | 2.46% |
| 2015 FY | 3.87 Billion EUR | 24.44% |
| 2015 Q4 | 1.05 Billion EUR | 4.05% |
| 2015 Q3 | 1.01 Billion EUR | 8.34% |
| 2015 Q2 | 935 Million EUR | 7.1% |
| 2014 FY | 3.11 Billion EUR | 4.11% |
| 2014 Q2 | 785 Million EUR | 18.22% |
| 2014 Q3 | 813 Million EUR | 3.57% |
| 2014 Q4 | 852 Million EUR | 4.8% |
| 2014 Q1 | 664 Million EUR | -19.32% |
| 2013 Q2 | 732 Million EUR | 6.24% |
| 2013 Q3 | 747 Million EUR | 2.05% |
| 2013 Q4 | 823 Million EUR | 10.17% |
| 2013 FY | 2.99 Billion EUR | 0.27% |
| 2013 Q1 | 689 Million EUR | -10.05% |
| 2012 Q4 | 766 Million EUR | -2.3% |
| 2012 FY | 2.98 Billion EUR | 16.39% |
| 2012 Q2 | 772 Million EUR | 16.79% |
| 2012 Q1 | 661 Million EUR | -5.71% |
| 2012 Q3 | 784 Million EUR | 1.55% |
| 2011 Q3 | 655 Million EUR | 3.64% |
| 2011 Q4 | 701 Million EUR | 7.02% |
| 2011 FY | 2.56 Billion EUR | 6.0% |
| 2011 Q2 | 632 Million EUR | 9.91% |
| 2011 Q1 | 575 Million EUR | -10.44% |
| 2010 FY | 2.41 Billion EUR | 17.61% |
| 2010 Q4 | 642 Million EUR | -1.98% |
| 2010 Q2 | 618 Million EUR | 23.6% |
| 2010 Q1 | 500 Million EUR | -10.71% |
| 2010 Q3 | 655 Million EUR | 5.99% |
| 2009 Q3 | 511 Million EUR | 0.59% |
| 2009 Q2 | 508 Million EUR | 6.5% |
| 2009 Q1 | 477 Million EUR | 0.0% |
| 2009 FY | 2.05 Billion EUR | 39.2% |
| 2009 Q4 | 560 Million EUR | 9.59% |
| 2008 FY | 1.47 Billion EUR | -65.88% |
| 2007 FY | 4.32 Billion EUR | 7.53% |
| 2006 FY | 4.02 Billion EUR | 28.22% |
| 2005 FY | 3.14 Billion EUR | 15.06% |
| 2004 FY | 2.72 Billion EUR | 260.5% |
| 2003 FY | 757 Million EUR | -6.54% |
| 2002 FY | 810 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 1.36 Billion EUR | 16.535% |
| LIMES Schlosskliniken AG | 5.02 Million EUR | -22642.245% |
| M1 Kliniken AG | 15.69 Million EUR | -7180.306% |
| Maternus-Kliniken Aktiengesellschaft | -9.26 Million EUR | 12443.413% |
| MEDICLIN Aktiengesellschaft | 12.72 Million EUR | -8884.595% |
| RHÖN-KLINIKUM Aktiengesellschaft | 40.39 Million EUR | -2729.278% |
| VITA 34 AG | -3.12 Million EUR | 36734.615% |